Private Equity 3 Days

Last updated: May 27, 2026, 5:32 PM ET

Tech Restructuring & AI Sentiment

Mass layoffs in U.S. tech reached 127,000 workers in 2025 and have not abated, with recent cuts adding to the turbulence that keeps investors wary of over‑leveraged growth stories. Amid this backdrop, CEOs are increasingly “suffering from AI psychosis,” a term coined by Box’s Aaron Levie to describe the blind faith in AI‑driven productivity gains that can skew valuation multiples and exit horizons. The convergence of cutbacks and hype pressures private‑equity sponsors to tighten due diligence, especially when chasing high‑growth, AI‑centric portfolio companies that may overstate future earnings.

Impact‑Focused Capital Allocation

Impact‑focused limited partners now demand an extra layer of scrutiny, using curated CVs to lock in mission commitments before committing capital. A panel at the PEI Group’s Impact Investor Global Summit highlighted that these CVs serve as a contractual anchor, ensuring that portfolio companies stay true to stated social or environmental goals. This trend dovetails with Dutch pension giant APG’s €615bn fund, which has broadened its impact mandate and is collaborating closely with general partners to hit a €10bn impact‑PE target, signalling a shift toward mission‑aligned returns without sacrificing profitability.

Dealmaking Momentum in Mid‑Market and Specialty Sectors

Carlyle’s Ian Fujiyama, recently named chairman of its U.S./Europe mid‑market platform, is eyeing attractive opportunities in advanced defense‑goods (ADG) services, citing rising demand for cyber‑secure and autonomous solutions that can command higher multiples. Meanwhile, Fortress announced the acquisition of IPValue, a licensing firm that has managed over 20,000 technology patents, positioning the firm to tap growing IP‑centric revenue streams in an era of patent‑heavy tech ecosystems. In a complementary move, Blackstone Life Sciences has secured up to $1.3bn in royalty and debt financing for Apogee Therapeutics, underscoring the continued appetite for life‑science IP that can generate steady royalty cash flows.

Cross‑Border Expansion and Roll‑Ups

Modella Capital’s purchase of Flying Tiger Copenhagen marks the firm’s most ambitious expansion yet, creating a high‑street retail platform that spans the United Kingdom and continental Europe. The deal illustrates how mid‑market sponsors are leveraging roll‑ups to generate scale and diversify revenue streams across borders, a strategy that has proven resilient amid supply‑chain shocks. In the U.S., Digital Bridge’s $1.05bn purchase of Arc Light, which includes a $650mn base price and up to $400mn contingent consideration, represents a strategic move into infrastructure assets that can deliver stable, inflation‑hedged cash flows in a high‑interest environment.

Data‑Centric Growth and AI Infrastructure

I Squared Capital’s commitment of up to $1bn to build a U.S. AI inference data‑centre platform signals a broader trend of PE firms investing in specialized infrastructure that supports the exploding demand for machine‑learning workloads. The capital will fund colocation sites tailored to AI inference, a niche that has attracted competitive bids from cloud giants but still offers higher margins for dedicated operators. Parallel to this, Capchase has closed a $200mn financing round comprising $26mn in equity and a $174mn credit facility, providing the company with the runway to scale its revenue‑based financing model as SMBs increasingly seek alternative capital sources.

Secondary Market Activity and Fund Formation

The secondary market remains vibrant, with CVC Credit reinforcing its stake in Curium, a Paris‑based nuclear‑medicine specialist, through a new debt and equity package that supports the company’s expansion plans. This move reflects a growing willingness among PE sponsors to combine debt and equity to accelerate growth in niche therapeutic areas where regulatory pathways are clear and reimbursement prospects strong. In a related development, the placement‑agent ranking released by PE International showed that agents raised $82bn in new capital for GP clients last year, a 12% increase from the previous cycle, indicating sustained LP appetite for diversified private‑equity exposure.

Portfolio M&A and Value Creation

EIV Capital’s promotion of Jason Tracton to partner follows his tenure as managing director of EIV Resources, highlighting the firm’s focus on operational expertise in resource‑heavy portfolios. Meanwhile, Xactus, backed by Lovell Minnick, has acquired a company that will operate as Xeda Link, a move that expands its footprint in the enterprise software market and positions the firm to capture synergies across its existing holdings. In the healthcare space, Sagely-backed Swoop’s acquisition of Nimble, a prescription‑management platform, illustrates the sector’s continued consolidation as firms seek to combine data analytics with patient engagement tools to improve outcomes and reduce costs.

Capital Deployment and Market Sentiment

PPM‑scale funds are also pulling in significant commitments: Eurazeo’s PME V closed with over €1bn in its first tranche, matching the size of its predecessor and demonstrating that mid‑market investors remain confident in Europe’s growth prospects despite geopolitical uncertainties. Conversely, the Dutch pension fund CPP Investments reported a net asset value of C$793.3bn at the end of fiscal 2026, up from C$714.4bn a year earlier, with private equity accounting for 22% of its portfolio—an indicator that institutional allocators are still prioritizing higher‑yield asset classes even as market volatility persists.

Conclusion

Across the private‑equity ecosystem sponsors are navigating a landscape marked by aggressive tech layoffs, heightened AI expectations, and a renewed focus on impact and mission alignment. Deal activity continues in both traditional mid‑market sectors and emerging data‑infrastructure niches, while secondary markets and fund formation remain robust. These dynamics suggest that, despite short‑term headwinds, the sector is poised to capitalize on disciplined value creation and strategic consolidation in high‑growth arenas.